Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04558151
Other study ID # 2020-PreopInsp
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 13, 2021
Est. completion date August 31, 2024

Study information

Verified date February 2023
Source University of Zurich
Contact Karin Pettersson
Phone +41442551111
Email Karin.Pettersson@usz.ch
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Rehabilitation strategies after abdominal surgery enhance recovery and improve outcome. A cornerstone of rehabilitation is respiratory physiotherapy with inspiratory muscle training to enhance pulmonary function. Prehabilitation is the process of enhancing functional capacity before surgery in order to compensate for the stress of surgery and postoperative recovery. There is growing interest in deploying pre-habilitation interventions prior to surgery. The aim of this study is to assess the impact of preoperative inspiratory muscle training on postoperative overall morbidity. The question is, whether inspiratory muscle training prior to elective abdominal surgery reduces the number of postoperative complications and their severity grade.


Description:

INSPIRA is a prospective randomized-controlled single-center trial, non-blinded The aim of this study is to assess the impact of preoperative inspiratory muscle training on postoperative overall morbidity. The question is, whether inspiratory muscle training prior to elective abdominal surgery reduces the number of post-operative complications and their severity grade. Furthermore, the impact of preoperative inspiratory muscle training on postoperative physiotherapeutic performance as surrogate of convalescence is assessed, too. Patients will be instructed by physiotherapists to perform inspiratory muscle training containing of 30 breaths twice a day for 14-18 days before surgery using Power®Breathe KHP2. Primary outcome is Comprehensive Complication Index (CCI) at 90 days after surgery. The CCI expresses morbidity on a con-tinuous numeric scale from 0 (no complication) to 100 (death) by weighing all postoperative complications according to the Clavien-Dindo classification for their respective severity.


Recruitment information / eligibility

Status Recruiting
Enrollment 134
Est. completion date August 31, 2024
Est. primary completion date January 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Informed Consent as documented by signature (Appendix Patient Informed Consent Form) - Planned abdominal surgery with planned duration >2hours (disease localization: upper vs. lower gastro intestinal, HPB, hernia, others) - Planned surgery at least two weeks after inclusion at outpatient clinic - Male and female patient over 18 years Exclusion Criteria: - Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, of the participant - Known or suspected non-compliance, drug or alcohol abuse, - Previous enrolment into the current study - Participation in another study with inspiratory muscle training within 30 days preceding or during this study

Study Design


Intervention

Behavioral:
preoperative inspiratory muscle training
Physiotherapists will measure the maximal inspiration pressure (MIP) with the POWER®breathe device of each single patient. Patients will then be instructed to perform inspiratory muscle training at the level of 60% of their individual MIP. Patients are instructed to perform the training containing of 30 breaths twice a day for 14-18 days before surgery. The devices are able to register the performance of each single training session and training results are monitored.

Locations

Country Name City State
Switzerland University Hospital Zurich Zurich

Sponsors (2)

Lead Sponsor Collaborator
University of Zurich Lunge Zuerich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative complications Postoperative complications measured by the comprehensive complication index (CCI) Com-prehensive Complication Index (CCI) 90 days after surgery. The CCI expresses postoperative morbidity on a continuous numeric scale from 0 (no complication) to 100 (death) by weighing all postoperative complications according to the validated Clavien-Dindo classification for their respective severity. It is measured at the end-of hospitalization and 90 days after surgery to include cases in which a readmission was necessary. Postoperative complications are gold standard in evaluation of quality of surgery as they directly reflect the procedures out-come and are most relevant for the patients. 90 days postoperative
Secondary Postoperative morbidity Secondary endpoints are the postoperative morbidity along the classification of Clavien-Dindo at the end of hospitalization as well as 90 days +/- 2 weeks after surgery. This classification consists of five (1-5) severity grades. Grade 1 reflects minor complications, while grade 5 re-flects death. The classification is widely accepted and validated to report postoperative compli-cations. At the end of hospitalization and 90 days +/- 2 weeks postoperative
Secondary Length of hospital stay (LOS) Length of postoperative hospital stay 90 days postoperative
Secondary Readmission rate Readmission rate as reflection of postoperative outcome. 90 days postoperative
Secondary Mortality Mortality as reflection of postoperative outcome. 90 days postoperative
Secondary Maximum inspiratory pressure (MIP) MIP is the most commonly used measure to evaluate inspiratory muscle strength. Very sensitive in detecting early respiratory muscle dysfunction, it allows for the assessment of ventilatory failure, restrictive lung disease and respirato-ry muscle strength and therefore represents a clinically meaningful trial endpoint. 5 days after surgery
Secondary Load Load (cmH20) (LOAD) is a measure of resistance to inhalation, and represents the pressure generated in the airways due to the force of the inspiratory muscles during a training session. As the training load decays with increasing lung volume (in order to match the length tension characteristics of the inspiratory muscles), the load displayed corresponds to the resistance at the start of inhalation (i.e. at RV). A higher load result means that the patient is training their inspiratory muscles hard-er, leading to stronger muscles. Stronger inspiratory muscles will need to work less hard to cope with the demands of breathing, leading to reduced breathlessness 5 days after surgery
Secondary Power (Watt) POWER is a measure of muscle performance which combines strength and speed of move-ment (Pressure x Flow). More powerful muscles will be more resistant to fatigue at a given level of work and therefore, breathlessness will be reduced. The value displayed is the average power for all breaths in a training session. 5 days after surgery
Secondary Sit-to-stand test During the sit-to-stand test, the quantity [n] how often a patient can sit down on a chair and stand up during 60 seconds is noted. These values are evaluated at admission to hospital for surgery and 5 days after surgery. 5 days after surgery
Secondary Energy (Joule) Breathing Energy) is a measure of the mechanical work (or effort) of breathing during your breathing training session. It is a result which combines the force exerted by your inspiratory muscles and the volume of air inhaled. The higher the value of breathing energy you attain, the longer and harder you have worked your inspiratory muscles. 5 days after surgery
Secondary Volume (l) Lung volume refers to the volume of gas the lungs and it represents the functions of the respiratory muscles and the mechanics of the lung and chest . 5 days after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT03181620 - Sedation Administration Timing: Intermittent Dosing Reduces Time to Extubation N/A
Recruiting NCT04205058 - Coffee After Pancreatic Surgery N/A
Completed NCT06425601 - A Comparison of Silicone Versus Polyvinylchloride (PVC) Drains Following VATS Lobectomy N/A
Completed NCT02565420 - Saline Versus Lactated Ringer's Solution: The SOLAR Fluid Trial N/A
Recruiting NCT04519593 - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma N/A
Completed NCT03662672 - Rib Raising for Post-operative Ileus N/A
Completed NCT03787849 - Epigenetics in PostOperative Pediatric Emergence Delirium N/A
Active, not recruiting NCT05886387 - a Bayesian Analysis of Three Randomised Clinical Trials of Intraoperative Ventilation
Not yet recruiting NCT06351475 - Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy N/A
Not yet recruiting NCT05052021 - The South African Coronavirus Disease of 2019 (COVID-19) Surgical Outcomes Study
Not yet recruiting NCT03591432 - A Trial Comparing Transnasal humidified Rapid insufflation Ventilatory Exchange (THRIVE) and Apneic Oxygenation With Facemask Ventilation in Elderly Patients Undergoing Induction of Anaesthesia. N/A
Not yet recruiting NCT03639012 - Outcomes of Carbohydrate Loading Paediatric Patients Preoperatively for Tonsillectomy and Adenoidectomy N/A
Not yet recruiting NCT03275324 - Use of Integrated Pulmonary Index to Predict Post-Operative Respiratory Adverse Events in High Risk Patients N/A
Recruiting NCT02763878 - Uncut Roux-en-y Anastomosis Reduce Postoperative Complication and Improve Nutritional Status After Distal Gastrectomy Phase 3
Completed NCT02891187 - Visits Versus Telephone Calls for Postoperative Care N/A
Completed NCT02947789 - Predictive Model for Postoperative Mortality N/A
Not yet recruiting NCT02542423 - Endocan Predictive Value in Postcardiac Surgery Acute Respiratory Failure. N/A
Completed NCT02766062 - Effects of Propofol and Sevoflurane on Early POCD in Elderly Patients With Metabolic Syndrome N/A
Recruiting NCT01934049 - Postoperative Recovery in Elderly Patients Undergoing Hip Hemi-arthroplasty Phase 4
Enrolling by invitation NCT01744938 - Preoperative Biliary Drainage for the Lower Malignant Obstructive Jaundice Phase 3

External Links